Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hodges Pure Contrarian Fund Retail Class (HDPCX)

Net Asset Value
1 Day
Overall Morningstar Rating
Small value
Style or Category
No Load
Sales Expenses
Expense Ratio
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. Under normal market conditions, the fund invests primarily in common stocks of companies with an attractive price and free cash flow. It will invest without regard to a company's market capitalization size. The fund may also invest up to 25% of its net assets in foreign equity securities, which includes investments in emerging markets. It also may invest in money market instruments and may, from time to time, purchase put and call options on U.S. traded stocks, currencies or security indices. The fund is non-diversified.


1 month-6.85% 3 years-4.88%
3 months-8.31% 5 years+5.68%
1 year-4.65% Since inception+7.37%
Data through --

Peer Comparisonvs. Small value

Performance 5-yr return+5.68%+12.47%
Expense ratio2.26%1.31%
Risk 5 year sharpe ratio0.500.97
Net assets$8.0M$1.0B
Average market cap$1.7B$2.9B
Average P/E11.218.7
Portfolio turnover185%185%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyHodges
Fund manager & tenureCraig Hodges / 7 Years
Minimal initial investment$1,000.00
Minimum IRA investment$1,000.00


U.S. stock85.88%
International stock12.79%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Consumer service 22.00%
Industrial materials 17.38%
Consumer goods 14.79%
Energy 14.14%
Media 12.60%
Top 10 Holdings
Portfolio weighting
VLRS Controladora Vuela Compania de Aviacion SAB de CV5.90%
CRK Comstock Resources Inc5.47%
CHS Chico's FAS Inc5.11%
CLF Cleveland-Cliffs Inc4.86%
GOGO Gogo Inc4.65%
REI Ring Energy Inc4.58%
AEO American Eagle Outfitters Inc4.15%
BAC Bank of America3.99%
CX Cemex SAB de CV3.84%
HZNP Horizon Pharma PLC3.75%